(NASDAQ: EAR) has been on a rampage of late, closing over $3.0 and making more than a 100% move from our original news post. The company moved on news the FDA will allow some hearing aid products to be sold over the counter. Shares are $2.81 today down 10% in pre-market trading and only 1.2million in volume.
RISK: This post is the author’s view of what’s happening and is not investment advice. The editors or others using this site can and will trade all stocks posted. Use this information at your own risk as you are responsible for your trading and losses. There is no guarantee any post will be updated and should be taken on an “as is basis” when posted. The market moves and changes quickly which makes the information contained in this post old very quickly.
